featured
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
Diabetes Care 2022 Dec 16;[EPub Ahead of Print], J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A DourosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.